Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy
- Conditions
- Metastatic Renal Cell Cancer
- Registration Number
- NCT00655252
- Lead Sponsor
- Novartis Pharmaceuticals
- Brief Summary
This expanded access study is designed to provide RAD001 to patients with MRCC who are without satisfactory treatment alternatives, until RAD001 becomes commercially available.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NO_LONGER_AVAILABLE
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- EXPANDED_ACCESS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (40)
The Cancer Institute, St. Joseph Medical Center
πΊπΈTowson, Maryland, United States
Indiana University Cancer center
πΊπΈIndianapolis, Indiana, United States
Cliveland Clinic Foundation
πΊπΈCleveland, Ohio, United States
Lakeridhe Health Corp - Oshawa
π¨π¦Oshawa, Ontario, Canada
Missouri Cancer Associates
πΊπΈColumbia, Missouri, United States
Moncton Hospital
π¨π¦Moncton, New Brunswick, Canada
University of Colorado Health Sciences Center/Anschutz Pavillion
πΊπΈAurora, Colorado, United States
Saskatoon Cancer Center
π¨π¦Saskatoon, Saskatchewan, Canada
Royal Victoria Hospital
π¨π¦Barrie, Ontario, Canada
QE ll Health Sciences Centre
π¨π¦Halifax, Nova Scotia, Canada
Centre Hospitalier Universitaire de Sherbrooke
π¨π¦Sherbrooke, Quebec, Canada
Washington University/Siteman Cancer Center
πΊπΈSt. Louis, Missouri, United States
St Luke's Wing, Royal Surrey County Hospital
π¬π§Surrey, United Kingdom
Highlands oncology Group, PA
πΊπΈSpringdale, Arkansas, United States
MD Anderson Cancer Center - Orlando
πΊπΈOrlando, Florida, United States
Cancer Centers of Florida, P.A.
πΊπΈOcoee, Florida, United States
Heartland Hematology-Oncology Associates, Inc.
πΊπΈKansas City, Missouri, United States
Blumenthal Cancer Center/Carolinas Medical Center
πΊπΈCharlotte, North Carolina, United States
Gabrail Cancer Center
πΊπΈCanton, Ohio, United States
Cleo Craig Memorial Cancer & Research Clinic
πΊπΈLawton, Oklahoma, United States
Cancer centers of the Carolinas
πΊπΈGreenville, South Carolina, United States
Novartis Investigative Site
πΉπ·Izmir, Turkey
Sault Area Hospital - General Site
π¨π¦Sault Ste Marie, Ontario, Canada
Les Urologues Associes du CHUM
π¨π¦Montreal, Quebec, Canada
Novartis Investigative site
π©πͺMunster, Germany
Royal Bournemouth Hospital
π¬π§Bournemouth, United Kingdom
Novartis Investidative Site
π©πͺNurnberg, Germany
Addenbrookes Hospital
π¬π§Cambridge, United Kingdom
British Haematology and Oncology Centre
π¬π§Bristol, United Kingdom
CRUK
π¬π§Glasgow, United Kingdom
Southampton University Hospital NHS Trust,
π¬π§Hampshire, United Kingdom
Royal Free Hospital
π¬π§London, United Kingdom
Oncology & Haematology Clinical Tirals Unit
π¬π§Leicester, United Kingdom
Guy's and St. Thomas' NHS Foundation Trust
π¬π§London, United Kingdom
Royal Marsden Hospital
π¬π§London, United Kingdom
The Christie Hospital
π¬π§Manchester, United Kingdom
Newcastle General Hospital
π¬π§Newcastle, United Kingdom
Mount Vernon Cancer Centre
π¬π§Northwood, United Kingdom
Singleton Hospital
π¬π§Swansea, United Kingdom
Henry Ford Health System
πΊπΈDetroit, Michigan, United States